Professor Robin Ali has been appointed as the Director of the NIHR Guy’s and St Thomas’ Biomedical Research Centre.
Professor Ali will take up the new position from his present role as Deputy Director of the BRC and Director of the BRC’s Advanced Therapies Accelerator with immediate effect.
Professor Ali has a record of world class translational research in the field of novel gene and cell therapies for retinal disorders and leads the new King’s Centre for Cell and Gene Therapy.
He leads King’s College London in advanced therapies, working to strengthen and enhance the delivery of the pipeline of gene and cell therapies from pre-clinical proof of concept to first-in-human studies and commercial development.
As the Director of the Advanced Therapies Accelerator, Professor Ali has also led on the implementation of the strategy for advanced therapies within our BRC.
Commenting on his appointment, Professor Ali said: “I am delighted to have the opportunity to lead the NIHR Guy’s and St Thomas’ BRC as its Director, and hope to build on its impressive research successes to date. In taking up the role I look forward to developing further collaborations with expert colleagues and teams here at the BRC and with other partners including with industry to deliver truly translational research for patient benefit.”
Professor Ian Abbs, Chief Executive of Guy’s and St Thomas’ said: “I am delighted to welcome Robin as the new Director for our BRC. His international reputation and expertise in translational cell and gene therapies research will ensure that Guy’s and St Thomas’ remains at the forefront of delivering improved therapies and treatments to patients – locally, nationally and globally.”
Professor Richard Trembath, Senior Vice President (Health and Life Sciences) at King’s College London added: “Robin brings with him the drive and translational research leadership necessary for the success of our BRC. I am very excited about the opportunities that his appointment opens for the BRC.”